ECTE Financial Facts
Other income (expense), net: 2.61MLoss from operations: -1.81M
See Full Income Statement
Preferred stock: 10K
Additional paid-in capital: 148.41M
See Full Balance Sheet
Echo Therapeutics (ECTE) Earnings
|
Expand Research on ECTE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -14.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/19/14 | Q314 | -$0.43 | N/A | N/A | $19.11M | $22.56M | N/A |  | | Details | |
8/14/14  |
Q214 | -$0.31 | -$0.23 | -$0.08 | $19.1M | $22.56M | N/A | | | Details | |
| 8/8/13 | Q213 | -$0.51 | -$0.81 | +$0.30 | $22.56M | $10M | N/A | | | Details | |
| 11/8/11 | Q311 | -$0.04 | -$0.05 | +$0.01 | N/A | $360K | N/A | | | Details | |
| 8/10/12 | Q212 | -$0.08 | -$0.07 | -$0.01 | $30.9K | $190K | N/A | | | Details | |
| 8/12/11 | Q211 | -$0.06 | -$0.06 | $0.00 | $121.46K | $100K | N/A | | | Details | |
| 5/11/12 | Q112 | -$0.08 | -$0.07 | -$0.01 | $30.93K | $80K | N/A | | | Details | |
| 11/8/12 | Q312 | -$0.11 | -$0.09 | -$0.02 | $30.9K | $40K | N/A | | | Details |
